Suppression of ventricular tachycardia by sotalol in myotonic dystrophy.
Cohen
M B
MB
Department of Medicine and Pediatrics, North Shore University Hospital-Cornell University Medical College, Manhasset, N.Y., USA.
Snow
J S
JS
Merkatz
K A
KA
Kholwadwala
D
D
Jadonath
R L
RL
Goldner
B G
BG
Cohen
T J
TJ
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D009223:Myotonic Dystrophy / Q000150:complications* / Q000503:physiopathology; D013015:Sotalol / Q000627:therapeutic use*; D017180:Tachycardia, Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D013015:Sotalol